Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
24.53
+0.54 (2.25%)
At close: Apr 28, 2026, 4:00 PM EDT
24.45
-0.08 (-0.33%)
Pre-market: Apr 29, 2026, 8:38 AM EDT
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of $2.41 billion as of April 29, 2026. Its market cap has decreased by -23.79% in one year.
Market Cap
2.41B
Enterprise Value
2.92B
1-Year Change
-23.79%
Ranking
Category
Stock Price
$24.53
Market Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $2.41B, an increase of 102.44%. That is a compound annual growth rate of 5.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 2.37B | 6.82% |
| Dec 31, 2025 | 2.22B | -42.88% |
| Dec 31, 2024 | 3.88B | -1.06% |
| Dec 29, 2023 | 3.93B | 20.90% |
| Dec 30, 2022 | 3.25B | -43.33% |
| Dec 31, 2021 | 5.73B | -32.17% |
| Dec 31, 2020 | 8.45B | 242.48% |
| Dec 31, 2019 | 2.47B | 12.20% |
| Dec 31, 2018 | 2.20B | 11.33% |
| Dec 29, 2017 | 1.98B | -31.24% |
| Dec 30, 2016 | 2.87B | -34.05% |
| Dec 31, 2015 | 4.36B | 211.25% |
| Dec 31, 2014 | 1.40B | 17.73% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vera Therapeutics | 2.66B |
| Tarsus Pharmaceuticals | 2.64B |
| Celldex Therapeutics | 2.61B |
| Enliven Therapeutics | 2.57B |
| Disc Medicine | 2.57B |
| IDEAYA Biosciences | 2.55B |
| ADMA Biologics | 2.53B |
| Zai Lab | 2.49B |